Substance / Medication

Verapamil

Overview

Active Ingredient
verapamil
RxNorm CUI
11170

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

20 trials linked to this intervention

20
Total Trials
5
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Is Verapamil Effective for Treating Patients With Chronic Rhinosinusitis With Nasal Polyps? A Systematic Review.
Yin Fangxing, Ali Haris, Abdelhalim Alaa et al. · Clin Otolaryngol · 2026
PMID: 41090403Meta-AnalysisFull text (PMC)
Evaluating the Concomitant Use of Diltiazem or Verapamil With Direct Oral Anticoagulants: A Meta-analysis.
Kido Kazuhiko, Shimizu Mikiko, Shiga Tsuyoshi et al. · Ann Pharmacother · 2026
PMID: 40326046Meta-Analysis
Verapamil in the treatment of reversible cerebral vasoconstriction syndrome: A systematic review.
Collins Luke, Lam Lydia, Kleinig Oliver et al. · J Clin Neurosci · 2023
PMID: 37267876Meta-Analysis
Comparative efficacy and safety of verapamil and triamcinolone in keloid and hypertrophic scar treatment: a meta-analysis.
Kuang Jing, An Ping, Li Wei · J Cosmet Laser Ther · 2021
PMID: 34278918Meta-Analysis
Efficacy and safety of verapamil vs triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis.
Liu Ruiquan, Yang Bin, Deng Zhu et al. · Dermatol Ther · 2020
PMID: 32400925Meta-Analysis
The β-cell effect of verapamil-based treatment in patients with type 2 diabetes: a systematic review.
Carnovale Carla, Dassano Alice, Mosini Giulia et al. · Acta Diabetol · 2020
PMID: 31172294Meta-Analysis
A snapshot of intralesional verapamil injection in the treatment of Peyronie's disease today.
Sadagopan Ananthan · Andrologia · 2019
PMID: 31475740Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Verapamil (substance)
SNOMED CT
372754009
UMLS CUI
C0042523
RxNorm CUI
11170

Clinical Data

This intervention maps to 15 entities in the Ltrl knowledge graph.

6
Conditions
4
Biomarkers
3
Specialists
0
Symptoms
20
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.